We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nanoco Group Plc | LSE:NANO | London | Ordinary Share | GB00B01JLR99 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.39 | 2.01% | 19.80 | 19.80 | 20.00 | 20.00 | 19.42 | 19.42 | 686,671 | 15:56:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 5.62M | 11.09M | 0.0343 | 5.71 | 63.38M |
The research project which has received the grant - entitled “VIVODOTS™ nano-devices for detection, resection and management of pancreatic cancers” - is a continued collaboration between Nanoco and University College London (“UCL”), the Group’s partner in the life sciences sector, and builds on the significant progress that Nanoco’s Life Sciences team has made on in-vivo mapping of sentinel lymph nodes and breast cancer imaging.
In support of the project, Nanoco will receive grant funding from Innovate UK of up to £484,689, representing 60% of the costs the Group expects to incur, paid quarterly in arrears over a three-year period.
The proposed VIVODOTS™ nano-device will enable more effective pre, intra and post-operative management of pancreatic cancers, resulting in better surgical treatment, higher cure rates, and better quality of life for survivors. Later development should lead to the extrapolation of the same concept to other types of deadly malignancies.
“As a business, we are proud to be working with a number of commercial and research institutions at the cutting edge of the battle against cancer, and this grant is testament to the scope of our ambition in the life sciences sector and the value of our technology in the clinical arena,” said Dr. Michael Edelman, CEO of Nanoco Group. “In this exciting project, we will be working with UCL to develop a groundbreaking cancer imaging therapeutic nano-device that will enable better detection and treatment of lethal types of tumors, particularly pancreatic tumors. The design will be based on the use of biocompatible and fluorescent quantum dot nanoparticles equipped with specific cancer targeting molecules; a major innovation that has already proved successful in our initial trials.”
ABOUT INNOVATE UKInnovate UK is the UK’s innovation agency. It works with people, companies and partner organizations to find and drive the science and technology innovations that will grow the UK economy.
For further information visit www.innovateuk.gov.uk.
ABOUT NANOCO Nanoco (LSE:NANO) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco’s proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications:
Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany, and Wah Hong Industrial Corporation of Taiwan. Through these partners and its own production facilities in Runcorn, UK, Nanoco is creating the world’s largest manufacturing ecosystem for cadmium-free quantum dots.
Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition. For further information visit: www.nanocogroup.com.
Media Contact: Colleen Irish Tier One Partners cirish@tieronepr.com (617) 842-1511
1 Year Nanoco Chart |
1 Month Nanoco Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions